Unilever PLC (UL) stands as a multinational consumer goods giant, producing and selling a broad portfolio that spans personal care products like Dove and Vaseline, beauty and wellbeing brands, home care items such as Domestos, and foods including Hellmann’s and Knorr. The company's business model centers on its power brands, which drive 78% of turnover, with a focus on premiumization, digital commerce, and innovation in high-growth areas like Beauty & Wellbeing and Personal Care. In the competitive consumer staples sector, Unilever maintains a strong global footprint, particularly in emerging markets like India and the US. Its fundamentals remain robust, evidenced by a 20.0% underlying operating margin in 2025 and €5.9 billion in free cash flow. From what I see, these strengths underpin the company's resilience even as the stock faces recent declines, with portfolio reshaping aimed at higher-growth segments amid currency volatility and market slowdowns.
In the last 30 days, UL stock has dropped sharply by about -20%, moving from a closing price of approximately $69.15 around March 3, 2026, to $55.45 as of April 2, 2026. The decline has been volatile and decidedly downward-trending, accelerating after March 31 with a -5% drop to $56.97 and further slides to a 52-week low near $54.95.
Over the past quarter, the stock is down roughly -14%, from around $64.56 in early January 2026 to current levels. It started range-bound but shifted lower on news events, accompanied by elevated trading volume on key days that surpassed 18 million shares.
The main trigger for UL's 30-day drop was the March 31, 2026, announcement of a $44.8 billion deal to combine Unilever's Foods business (excluding India) with MKC, forming a $20 billion flavor entity. Unilever shareholders would own 65% of the combined company plus $15.7 billion in cash, yet the market reacted poorly to the complex Reverse Morris Trust structure, the long timeline to close by mid-2027, antitrust risks, and potential dilution. This sparked a 5-7% single-day plunge, erasing billions in market value. Ongoing pressure stemmed from analyst downgrades—like those from DZ Bank and Kepler moving from Buy to Hold—and reports of a global hiring freeze amid challenges such as the U.S.-Iran war. Weakening sentiment in consumer staples, driven by slowing demand, added to the downtrend. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against industry peers.
The -14% quarterly decline in UL built from earlier headwinds exposed in the February 12, 2026, Q4/full-year 2025 earnings, which delivered 3.5% underlying sales growth but missed on revenue ($12.59B vs. expectations) and EPS ($0.75 vs. $1.75). Currency headwinds at -5.9% and the Ice Cream demerger weighed on free cash flow. Persistent themes included portfolio transformation via 10 M&A deals, with strength in Beauty & Wellbeing (4.3% growth), but concerns over emerging market slowdowns—like in Latin America—and institutional selling persisted. Macro factors such as inflation, higher rates, and regulatory scrutiny on deals intensified the pressure, culminating in the McCormick news. Unilever's defensive qualities provided some buffer, though overall sentiment turned negative.
In my own research process, I often turn to Tickeron’s Trending AI Robots page, which highlights the top performers from its library of hundreds of algorithms trading thousands of tickers across markets. This section focuses on the most relevant bots based on recent results, employing strategies like momentum, mean reversion, or scalping, and key metrics such as win rate, Sharpe ratio, and average returns across timeframes from intraday to long-term. Powered by advanced machine learning, these bots analyze price movements and trends without emotional interference, helping me uncover data-driven opportunities. One thing that stands out is how they can align with different trading styles to potentially improve portfolio outcomes—worth exploring if you're looking for an edge.
Looking ahead, I'm watching progress on the McCormick Foods deal closely, including regulatory approvals and shareholder votes, as any delays or antitrust hurdles could shift sentiment. Upcoming quarterly earnings will shed light on 2026 guidance for 4-6% underlying sales growth (likely at the low end) and modest margin expansion. Trends like premiumization in Beauty & Wellbeing and e-commerce growth remain central. Broader factors—currency swings, inflation, interest rates, and geopolitical tensions impacting demand—deserve attention. Strategic moves such as the €1.5 billion share buyback, €800 million productivity savings target, and M&A in high-growth areas could support the stock, balanced against risks from hiring freezes or market slowdowns. This is important because these elements will shape near-term price action.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The 10-day RSI Oscillator for UL moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In 13 of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at 43%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UL as a result. In 33 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.
The Moving Average Convergence Divergence Histogram (MACD) for UL turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 15 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 34%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
UL moved above its 50-day moving average on November 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UL crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +1.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where UL advanced for three days, in 147 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
UL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 59 of 199 cases where UL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 30%.
The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. UL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.776) is normal, around the industry mean (21.731). P/E Ratio (15.529) is within average values for comparable stocks, (16.288). UL's Projected Growth (PEG Ratio) (6.572) is very high in comparison to the industry average of (1.518). Dividend Yield (0.032) settles around the average of (0.032) among similar stocks. P/S Ratio (2.336) is also within normal values, averaging (1.902).
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of fast moving consumer goods
Industry HouseholdPersonalCare